mavorixafor

1,4-Butanediamine, N~1~-(1H-benzimidazol-2-ylmethyl)-N~1~-[(8S)-5,6,7,8-tetrahydro-8-quinolinyl]-

558447-26-0

mavorixafor

mavorixafor

mavorixafor

mavorixaforum

N-(1H-Benzimidazol-2-ylmethyl)-N-[(8S)-5,6,7,8-tetrahydro-8-chinolinyl]-1,4-butandiamin

N-(1H-Benzimidazol-2-ylméthyl)-N-[(8S)-5,6,7,8-tétrahydro-8-quinoléinyl]-1,4-butanediamine

N-(1H-Benzimidazol-2-ylmethyl)-N-[(8S)-5,6,7,8-tetrahydro-8-quinolinyl]-1,4-butanediamine

马伏沙福

(S)-N1-((1H-benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

4-aminobutyl-(1H-benzimidazol-2-ylmethyl)-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]amine

558447-26-0 (free)

62470-53-5

A0A090N8Q0_HUMAN

ACHA7_HUMAN

ACM2_HUMAN

ADA2A_HUMAN

AMD-070 (AMD11070)

C-X-C chemokine receptor type 4

CP2D6_HUMAN

CP3A4_HUMAN

CXCR4_HUMAN

Cytochrome P450 2D6

Cytochrome P450 3A4

D(2) dopamine receptor

DRD2_HUMAN

KCNH2_HUMAN

mavorixaforum

MFCD11977316

Muscarinic acetylcholine receptor M2

N-(1H-benzimidazol-2-ylmethyl)-N-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine

N1-(1H-benzimidazol-2-ylmethyl)-N1-[(8S)-5,6,7,8-tetrahydro-8-quinolinyl]-1,4-butanediamine

N′-(1H-benzimidazol-2-ylmethyl)-N′-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine

OPRK_HUMAN

OPRM_HUMAN

X4P-001

X4P-001-LD

α-2A adrenergic receptor

κ-type opioid receptor

μ-type opioid receptor

马伏沙福